about
The cytotoxic effect of α-tomatine in MCF-7 human adenocarcinoma breast cancer cells depends on its interaction with cholesterol in incubation media and does not involve apoptosis induction.Determination of pteridines in biological samples with an emphasis on their stability.Ferns and lycopods--a potential treasury of anticancer agents but also a carcinogenic hazard.The Steroidal Glycoalkaloids from Solanaceae: Toxic Effect, Antitumour Activity and Mechanism of Action.Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.The anticancer activity of alpha-tomatine against mammary adenocarcinoma in mice.Boldine enhances bile production in rats via osmotic and farnesoid X receptor dependent mechanisms.Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2.Increased melibiose/rhamnose ratio in bile of rats with acute cholestasis.Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis.The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice.Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice.Boldine Inhibits Mouse Mammary Carcinoma In Vivo and Human MCF-7 Breast Cancer Cells In Vitro.Evaluation of the antineoplastic activity of mitoxantrone-L-carnitine combination therapy on an experimental solid form of ehrlich tumour in mice.In-vitro and in-vivo evaluation of the anticancer activity of diruthenium-2, a new trithiolato arene ruthenium complex [(η6-p-MeC6H4Pri)2Ru2(μ-S-p-C6H4OH)3]Cl.Biochemical and Pharmacological Effects of Mitoxantrone and Acetyl-L-Carnitine in Mice with a Solid Form of Ehrlich TumourDevelopment of an HPLC fluorescence method for determination of boldine in plasma, bile and urine of rats and identification of its major metabolites by LC-MS/MS
P50
Q37341326-6B6B1E86-FDBB-4841-BA46-F1BC3A138CE8Q38140004-E005F1D2-0B0A-45BB-B8BE-7F87430DB562Q38152399-2E1C5196-D279-4942-B282-16B09CC21014Q38723181-B8E6F7AA-FF5E-4AC7-B8A1-F05EB349A9A1Q38781054-9DC8EC0E-F465-4BBA-A08D-7845546AC4DDQ39417665-C3C651C8-62CE-47E8-8E89-C487F064F113Q42702286-D690B988-79FF-4D48-B869-FD5332658400Q42714287-58FDD2D1-B4DC-40AA-94AB-F6E57DB70C75Q46418648-70093CD4-B485-4C65-9B5A-A9164A188536Q50066253-28935B98-E619-4BBC-844F-CE4AEEB98B52Q50117033-B252AE70-2E30-4113-AAAF-64290D181344Q50516903-40D6E8F7-6DCD-4E2F-9D25-FBBE6CDB9AECQ51525552-9BC2CD46-C1CE-4657-9728-89152006E194Q51930746-497386B4-694E-4F29-A0E1-AE4FB97FCBEEQ52869000-A8B4C566-768F-4592-B201-6483DD02F739Q62082192-8E2C8CF4-3F15-41D5-841E-2B792B964FB2Q87304788-EE792167-7110-4A43-BC73-82B93D994287
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Pavel Tomsik
@ast
Pavel Tomsik
@es
Pavel Tomsik
@nl
Pavel Tomsik
@sl
Pavel Tomšík
@cs
Pavel Tomšík
@en
type
label
Pavel Tomsik
@ast
Pavel Tomsik
@es
Pavel Tomsik
@nl
Pavel Tomsik
@sl
Pavel Tomšík
@cs
Pavel Tomšík
@en
altLabel
Pavel Tomsik
@en
prefLabel
Pavel Tomsik
@ast
Pavel Tomsik
@es
Pavel Tomsik
@nl
Pavel Tomsik
@sl
Pavel Tomšík
@cs
Pavel Tomšík
@en
P214
P1053
E-7720-2017
P106
P1153
24559186900
P21
P214
P31
P3829
P496
0000-0002-4366-075X
P569
1977-01-01T00:00:00Z